HSBC Trinkaus & Burkhardt GmbH Share Price

Certificat

DE000HS3DD92

Real-time BOERSE MUENCHEN 08:40:07 18/07/2024 BST
101 EUR +0.23% Intraday chart for HSBC Trinkaus & Burkhardt GmbH
Current month-0.03%
1 month+0.54%
Date Price Change
18/07/24 101 +0.23%
17/07/24 100.7 -0.25%
16/07/24 101 -0.08%
15/07/24 101 -0.19%
12/07/24 101.2 -0.03%

Real-time BOERSE MUENCHEN

Last update July 18, 2024 at 08:40 am

More quotes

Static data

Product typeObligations Convertibles
Buy / SellCALL
Underlying SANOFI
Issuer HSBC
WKN HS3DD9
ISINDE000HS3DD92
Date issued 17/11/2023
Strike 80
Maturity 20/12/2024 (156 Days)
Parity 0.08 : 1
Emission price 99.53
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 102.7
Lowest since issue 98.81
Spread 1
Spread %0.10%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
92.02 EUR
Average target price
108.6 EUR
Spread / Average Target
+17.97%
Consensus